Postdoctoral researchers are advancing new cancer treatment approaches.
This #PostdocAppreciationWeek, meet Anca Apavaloaei, PhD, a CRI postdoctoral fellow at @WeillCornell who studies new cancer vaccine targets to help the immune system fight cancer.
bit.ly/4h7R2P7
The Rudensky Symposium brought together scientists across generations to explore immunology and cancer while celebrating Alexander “Sasha” Rudensky, PhD, of @MSKCancerCenter. bit.ly/4iAADE2
What if a tissue sample could help reveal which #cancertreatment is most likely to work for a patient?
Meet Julie Deutsch, MD, a 2026 CRI STAR at @JohnsHopkins, who uses #pathology and machine learning to match patients with the right therapy. bit.ly/4xVZJlo
Proud to support Shayna Thomas-Jardin, PhD, through a CRI IGNITE Award as she investigates how cancer cells survive stress and evade the immune system. #CancerResearch#CancerImmunotherapy
UTSW postdoc Shayna Thomas-Jardin, Ph.D., is studying how cancer cells survive stress and evade immune attack – research that earned her a @CancerResearch Institute IGNITE Award. Read how her research could help uncover new ways to target cancer: bit.ly/4y7qjrn
This #WorldGratitudeDay, we’re grateful for the donors who support our mission, the researchers advancing the science, the patients and families who inspire our work, and everyone who stands with us. Thank you.
📢 Applications are now open for CRI’s 2027 CLIP grants.
Up to $1M over three years is available for teams advancing immune-based approaches to cancer prevention and interception.
📅 LOI deadline: Dec. 1, 2026
Learn more + apply: bit.ly/4ywtOrL
CRI is proud to announce Reed Jobs, founder of Yosemite, as the 2026 Oliver R. Grace Award recipient.
His bold approach to philanthropy and investment is helping move promising cancer discoveries closer to patients.
Learn why he's being honored: bit.ly/4hieQja
CAR T-cell therapy has transformed treatment for certain lymphomas. But what do we know about life after treatment?
This #WorldLymphomaAwarenessDay, learn how researchers are studying CAR T-cell therapy’s potential impact on fertility: bit.ly/4A5my7K
This #PostdocAppreciationWeek, we celebrate the early-career scientists whose bold ideas are helping shape the future of cancer treatment.
Meet the 2025–2026 CRI Postdoctoral Fellows helping build a world immune to cancer: bit.ly/3UC0e5z
Before cancer develops. Before it takes hold. Before it returns.
Researchers are exploring 3 windows to act:
1️⃣ Primary prevention
2️⃣ Cancer interception
3️⃣ Preventing recurrence
Explore how science is creating new opportunities to intervene: bit.ly/3V118Zn
What makes ovarian cancer difficult to detect early?
Symptoms like bloating, pelvic pain, feeling full quickly & urinary changes can be easy to overlook.
This #OvarianCancerAwarenessMonth, explore how immunotherapy is advancing treatment: bit.ly/3SSMHFY
In FY 2025–26, CRI made its largest grantmaking investment to date: $34.4 million in new funding supporting 93 awards across 50 institutions, 17 U.S. states, and five countries.
Explore: bit.ly/3UBV2P0
Once considered a disease of older adults who smoke, the rise of lung cancer in nonsmokers and young adults is an alarming trend. #LCINS is now recognized as a distinct disease entity that is biologically different from lung cancer caused by smoking:
bit.ly/4hb2VEl
Behind every patient is a village, with each person playing a part in the cancer journey, offering support in ways both big and small. During #WorldCancerSupportMonth, CRI is highlighting patients' stories about their villages: bit.ly/3SE3igC
If you’re considering a clinical trial, having an open conversation with your doctor is an important first step. Discover 10 questions you can ask your doctor about clinical trials, on our website: bit.ly/4tXh0Z5#ClinicalTrial#CancerResearch#Immunotherapy